GORMAN RUPP CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GORMAN RUPP CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	382	379	414	398	349	378	521	660	660	682
Cost of revenue	290	278	304	296	259	282	390	463	455	473
Gross profit	92.5	101	110	103	89.6	95.9	131	196	204	209
Selling, general and administrative	54.3	55.5	59.3	58.8	52.7	56	83.1	96.7	101	101
General and administrative							47.5	51.4	51.6	53.2
Operating income	36.4	41.6	50.6	43.8	35.8	39.4	40.2	87	91.4	95.4
Interest expense	0.02	0.02	0	0.1	0	0	19.2	41.3	33.6	23.4
Other non-operating income	0.05	-2.26	-0.32	1.33	-4.51	-2.11	-7.07	-1.81	-7.33	-2.8
Pre-tax income	36.5	39.4	50.3	45.2	31.2	37.2	13.9	44	50.5	69.2
Income tax	11.6	12.8	10.3	9.35	6.06	7.4	2.68	9.01	10.4	16.1
Net income	24.9	26.6	40	35.8	25.2	29.9	11.2	35	40.1	53
EBITDA	52	56.7	65.1	57.6	48.4	51.3	61.3	116	119	123
EPS, basic	0.95	1.02	1.53	1.37	0.97	1.14	0.43	1.34	1.53	2.02
EPS, diluted	0.95	1.02	1.53	1.37	0.97	1.14	0.43	1.34	1.53	2.02
Shares, basic (weighted)	26.1	26.1	26.1	26.1	26.1	26.1	26.1	26.2	26.2	26.3
Shares, diluted (weighted)	26.1	26.1	26.1	26.1	26.1	26.1	26.1	26.2	26.2	26.3
Dividend per share			2.51		0.59	0.64

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	57.6	79.7	46.5	80.6	108	125	6.78	30.5	24.2	35.1
Receivables	71.4	67.4	67.7	65.4	50.8	58.5	93.1	89.6	87.6	88.4
Inventory	69	75	87.4	76	82.7	85.6	111	104	99.2	96.5
Other current assets	5.82	5.92	7.13	5.68	5.17	7.8	14.6	11.8	9.77	13.8
Total current assets	204	228	209	228	247	277	226	236	221	234
Property, plant and equipment	122	117	113	112	109	104	129	135	132	134
Lease right-of-use assets				1.26	1.25			20.1	19	18.3
Goodwill	28	27.6	27.2	27.2	27.5	27.2	258	258	258	258
Intangible assets							236	211		199
Other non-current assets	7.77	7.78	5.1	8.32	4.8	6.19	11.6	24.8	23.8	22.2
Total assets	383	395	368	383	394	421	873	890	858	860
Accounts payable	16.3	15.8	16.7	16	9.47	17.6	24.7	23.9	24.8	25.9
Accrued liabilities	9.19	9.82	4.68	5.35	4.58	5.69	9.03	12	10	12.3
Deferred revenue	1.36	0.46	5.23	4.91	8	9.2	6.74	12.5	6.84	7.66
Short-term debt						0	17.5	21.9	18.5	23.1
Total current liabilities	49.4	45.7	48.5	45.5	38.5	52.4	85.2	101	87.5	98.6
Long-term debt						0	419	383	348	284
Lease liabilities								19.8	18.8	18.3
Other non-current liabilities								23.4	20.2	32.4
Total liabilities	79.9	69.5	75.2	74.9	78.9	90.8	542	541	485	445
Total debt						0	437	404	367	308
Paid-in capital	0.22	0.53	2.54	1.15	0.69	1.84	3.91	5.75	9.36	11.5
Retained earnings	318	332	309	330	340	353	347	364	385	418
Other comprehensive income	-20.5	-12.5	-23.4	-28.5	-30.4	-30.3	-24.5	-24.9	-25.4	-20.4
Shareholders' equity	303	325	293	308	316	330	331	349	374	415
Total equity	303	325	293	308	316	330	331	349	374	415
Total liabilities and equity	383	395	368	383	394	421	873	890	858	860
Shares outstanding	26.1	26.1	26.1	26.1	26.1	26.1	26.1	26.2	26.2	26.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	24.9	26.6	40	35.8	25.2	29.9	11.2	35	40.1	53
Depreciation and amortization	15.5	15.1	14.5	13.7	12.7	11.9	21.2	28.5	27.9	27.7
Stock-based compensation	0.25	0.74	1.67	1.03	0.04	2.4	2.96	3.25	4.01	3.58
Deferred income tax	3.51	-6.14	0.34	-1.2	0.54	0.05	-1.09	-0.41	-1.42	10.3
Change in receivables	5.27	5.47	-1.2	2.22	15.2	-8.7	-14	3.75	1.18	0.88
Change in inventory	13.9	-4.31	-13.6	11.5	-6.28	-11	-32.8	0.56	-2.03	1.18
Change in payables	1.39	-1.27	1.3	-0.6	-6.85	8.72	-2.25	-1.52	1.22	0.45
Cash from operations	53.4	43.3	41.2	62.2	51.2	45.4	13.7	98.2	69.8	106
Capital expenditures	-6.88	-7.75	-10.9	-10.9	-8	-9.75	-18	-20.8	-14.3	-17.4
Acquisitions	-2.97				0	0	-528	0	0
Purchases of investments		-2.98
Cash from investing	-8.47	-10.4	-7.47	-10.8	-7.7	-9.17	-546	-20.2	-11.9	-15.3
Debt issued					0	0	457	5	400	0
Debt repaid					0	0	-8.75	-39.5	-443	-60
Share buybacks			0	-2.61	-0.36	-1.25	-0.92	-1.03	-0.27	-1.15
Dividends paid	-11.2	-12.3	-13.3	-14.4	-15.4	-16.6	-17.9	-18.4	-19	-19.6
Cash from financing	-11.2	-12.3	-65.6	-17.4	-16.1	-18.6	414	-54.5	-63.1	-80.9
Exchange rate effect	0.13	1.49	-1.41	0.13
Net change in cash	33.9	22.1	-33.2	34.1	27.6	17	-118	23.7	-6.31	10.9
Free cash flow	46.6	35.5	30.3	51.3	43.2	35.7	-4.3	77.4	55.5	88.9
Interest paid					0	0	17.4	35.9	33.6	22.2
Income taxes paid	7.8	13.5	14.7	9.1	6.2	7.9	4.5	7.9	10.2	8.43

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $74.21 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.4%	Gross profit / revenue.
Operating margin	14.8%	Operating income / revenue.
EBITDA margin	17.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.5%	Pre-tax income / revenue.
Net margin	8.9%	Net income / revenue.
FCF margin	14.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.1%	Cash from operations / revenue.
Effective tax rate	22.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.2%	Net income / average total assets.
Return on invested capital (ROIC)	11.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	16.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	33.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	21.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	3.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	26.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	20.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	32.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	67.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	16.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	32.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	67.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	52.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	98.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	15.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	60.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	15.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	16.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.81x	Current assets / current liabilities.
Quick ratio	1.71x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.49x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.62x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	31.7%	Total debt / total assets.
Liabilities / assets	49.1%	Total liabilities / total assets.
Net debt	$231.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.86x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.00x	Operating income / interest expense.
Working capital	$159.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	29.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$183.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.81x	Revenue / average total assets.
Fixed asset turnover	5.27x	Revenue / average property, plant and equipment.
Inventory turnover	5.52x	Cost of revenue / average inventory.
Days inventory	66 days	365 x average inventory / cost of revenue.
Receivables turnover	6.51x	Revenue / average receivables.
Days sales outstanding	56 days	365 x average receivables / revenue.
Days payables	23 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	99 days	Days inventory + days sales outstanding - days payables.
FCF conversion	161.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.36	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.59	Revenue / diluted weighted shares.
FCF per share	$3.81	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.54	Cash from operations / diluted weighted shares.
Book value per share	$16.71	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.95	Tangible book value / shares outstanding.
Cash per share	$1.65	(Cash + short-term investments) / shares outstanding.
Payout ratio	31.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	19.8%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	2.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.96B	Share price x shares outstanding.
Enterprise value	$2.19B	Market cap + total debt - cash - short-term investments.
P/E	31.4x	Market cap / net income. Only when net income is positive.
P/S	2.79x	Market cap / revenue.
P/B	4.44x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	10.7x	Market cap / tangible book value, when positive.
P/FCF	19.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	16.4x	Market cap / cash from operations, when positive.
EV/Sales	3.12x	Enterprise value / revenue.
EV/EBIT	21.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	21.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.1%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Dividend yield	1.0%	Dividends paid over the period / market cap.
Shareholder yield	1.1%	(Dividends paid + share buybacks) / market cap.
PEG	0.47x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was GORMAN RUPP CO's revenue in fiscal 2025?

GORMAN RUPP CO reported revenue of $682.4M for fiscal 2025, 3.4% higher than the year before.

Was GORMAN RUPP CO profitable in fiscal 2025?

Yes. Net income was $53.0M, a net margin of 7.8%.

How much free cash flow did GORMAN RUPP CO generate in fiscal 2025?

Cash from operations of $106.2M minus capital expenditures of $17.4M left free cash flow of $88.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GORMAN RUPP CO